Advertisement

Related Videos

Ian Tannock, MD, PhD, DSc, on Near-Equivalence: A Better Question Than Non-Inferiority

Peter Clark, MA, MD, FRCP: A Payer Perspective

Clinical Trial Design: Statistical Options/Challenges Panel Discussion

Varsha Gandhi, PhD, on Ibrutinib

Blase Polite, MD, MPP, FASCO, on Transforming the Drug Cost Curve in the United States: Not How But If

Advertisement

Advertisement




Nov
20
Today In Oncology
New Computational Tool Shows Strong Accuracy in Predicting Cancer Drug Targets
Long-Term Survival With vs Without Postmastectomy Chest Wall Irradiation in Breast Cancer
Newly Diagnosed AL Amyloidosis FDA Grants Traditional Approval to Regimen
Curative Treatment After First-Line Immunotherapy Improves Survival in HCC
FDA Approves Selumetinib for Adults With NF1 With Symptomatic, Inoperable Plexiform Neurofibromas
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo